Other

Maxwell Zachary Price

Richard Louis Price

Disclosed are methods of treating a patient having Major Depressive Disorder (MDD). The methods include administering to the patient a therapeutically effective amount of bupropion hydrobromide in extended-release form. The methods are more therapeutically effective in treating MDD than administration of an equivalent plasma dose of bupropion hydrochloride in extended-release form. Optionally, in addition, the therapeutically effective amount of bupropion hydrobromide reduces the incidence of one or more adverse events (anxiety, agitation and/or insomnia), when compared to the administration of the equivalent plasma dose of bupropion hydrochloride in extended-release form.

Therapeutic methods using bupropion hydrobromide to treat Major Depressive Disorder

Disclosed are methods of treating a patient having Major Depressive Disorder (MDD) or Treatment Resistant Depression (TRD). The methods include administering to the patient a therapeutically effective amount of bupropion hydrobromide in extended-release form. The methods are more therapeutically effective in treating MDD or TRD than administration of an equivalent plasma dose of bupropion hydrochloride in extended-release form. In addition or alternatively, the therapeutically effective amount of bupropion hydrobromide reduces the incidence of one or more adverse events (anxiety, agitation and/or insomnia), when compared to the administration of the equivalent plasma dose of bupropion hydrochloride in extended-release form.

Therapeutic methods using bupropion hydrobromide

Methods are provided for inhibiting cyanobacteria. The methods include treating a substance contaminated with cyanobacteria with a composition. The composition includesLinn. or an extract of the same.

Growing community of inventors

Suffern, NY, United States of America

Maxwell Zachary Price